Anti-IL5/IL-5 receptor therapies for eosinophilic granulomatosis with polyangiitis: an updated Systematic Review

Anti-IL5/IL-5 receptor therapies for eosinophilic granulomatosis with polyangiitis: an updated Systematic Review

IntroductionEosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare necrotizing vasculitis characterized by eosinophilic inflammation that was traditionally treated with corticosteroids associated with other immunosuppressants. Over the last years different biological therapies targeting IL-5...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Lazzeroni, Valeria Longoni, Paolo Schiavo, Emanuele Bizzi, Antonio Brucato, Giulia Gramellini, Marco Borin, Alberto Dragonetti, Michele Gaffuri, Mario Lentini, Antonino Maniaci, Angela Mauro, Antonio Gidaro, Jan Schroeder, Pasquale Capaccio
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
EGPA
IL5
eosinophil
mepolizumab
benralizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1587158/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1587158/full

Similar Items